Autolus Therapeutics plc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2016 Sep2017 Sep2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.01B
Gross Profit -0.00B
Operating items
Research & Development 0.01B0.02B0.04B0.11B0.13B0.11B0.12B0.13B0.14B
Wages, Salaries and Other 2.61B0.00B
Selling, General & Administrative 0.01B0.01B0.02B0.04B0.03B0.03B0.03B0.05B0.10B
Other Operating Expenses -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Operating Expenses 0.01B0.02B0.06B0.14B0.17B0.14B0.15B0.18B0.25B
Operating Income -0.02B-0.06B-0.15B-0.17B-0.14B-0.14B-0.18B-0.24B
EBIT -0.01B-0.02B-0.06B-0.15B-0.17B-0.14B-0.14B-0.18B-0.24B
Non-operating items
Interest & Investment Income 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.03B
Other Non Operating Income -0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B
Non Operating Income 0.00B-0.00B0.01B0.01B0.00B-0.00B-0.01B-0.03B0.02B
Net income details
EBT -0.01B-0.02B-0.05B-0.14B-0.17B-0.14B-0.15B-0.21B-0.22B
Tax Provisions -0.00B-0.00B-0.01B-0.02B-0.02B0.00B0.00B-0.00B0.00B
Profit After Tax -0.01B-0.02B-0.04B-0.12B-0.14B-0.14B-0.15B-0.21B-0.22B
Income from Continuing Operations -0.01B-0.02B-0.04B-0.12B-0.14B-0.14B-0.15B-0.21B-0.22B
Consolidated Net Income -0.01B-0.02B-0.04B-0.12B-0.14B-0.14B-0.15B-0.21B-0.22B
Income towards Parent Company -0.01B-0.02B-0.04B-0.12B-0.14B-0.14B-0.15B-0.21B-0.22B
Net Income towards Common Stockholders -0.01B-0.02B-0.04B-0.12B-0.14B-0.14B-0.15B-0.21B-0.22B
Additional items
EPS (Basic) -1.26-1.43-1.42-2.88-2.76-1.97-1.57-1.20-0.86
EPS (Weighted Average and Diluted) -2.88-2.76-1.97-1.57-1.20-0.86
Shares Outstanding (Weighted Average) 0.04B0.04B0.04B0.05B0.07B0.09B0.27B0.27B
Shares Outstanding (Diluted Average) 0.17B0.26B
EBITDA -0.02B-0.02B-0.05B-0.12B-0.14B-0.14B-0.18B-0.20B-0.22B
Interest Expenses 0.00B0.01B0.05B0.01B
Shares Outstanding 90.91B173.07B0.00B0.00B
Tax Rate 12.4015.8314.0310.9314.560.01